Patent · US Active

8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals

US8637530B2 · kind B2 · utility

28Cited by

97References

18Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Waldemar Pfrengle · Seibersbach, DE
Peter Sieger · Mittelbiberach, DE

Key dates

Filing date	Jan 9, 2012
Grant date	Jan 28, 2014
Priority date	—
Expiry date	Jan 9, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 8-[3-amino-piperidin-1-yl]-xanthines and the physiologically acceptable salts thereof, particularly the hydrochlorides thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.